 |
|
Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice
David J. Seiffge, Christopher Traenka, Alexandros A. Polymeris, Sebastian Thilemann, Benjamin Wagner, Lisa Hert, Mandy D. Müller, Henrik Gensicke, Nils Peters, Christian H. Nickel, Christoph Stippich, Raoul Sutter, Stephan Marsch, Urs Fisch, Raphael Guzman, Gian Marco De Marchis, Philippe A. Lyrer, Leo H. Bonati, Dimitrios A. Tsakiris, Stefan T. Engelter
J Stroke. 2017;19(3):347-355. Published online 2017 Sep 6 DOI: https://doi.org/10.5853/jos.2017.00395
|
|
Citations to this article as recorded by
 Intravenous thrombolysis and mechanical thrombectomy in acute stroke patients on direct oral anticoagulants
Espen Saxhaug Kristoffersen, David Julian Seiffge, Thomas Raphael Meinel
Journal of Neurology.2025;[Epub] CrossRef Intravenous thrombolysis for patients with acute ischemic stroke while receiving a direct oral anticoagulant: A systematic review and meta‐analysis
Megan Z. Roberts, Spencer H. Durham, Nathan A. Pinner, Jessica A. Starr
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.2025; 45(2): 111. CrossRef A Pilot Study to Evaluate an International Normalized Ratio-Derived Formula in Combination with Heparin-Calibrated Anti-Xa Activity in Calculating a Plasma Edoxaban Level
Chun-Fung Sin, Pui-Yee Chan, Yi-Teng Hoo, Wang-Ho Yuen, Hoi-Ching Wong
Journal of Clinical Medicine.2025; 14(3): 1006. CrossRef Risk of Bleeding Following Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Acute Ischemic Stroke Treated With Alteplase
Tou-Yuan Tsai, Yu-Chang Liu, Wan-Ting Huang, Yu-Kang Tu, Shang-Quan Qiu, Sameer Noor, Yong-Chen Huang, Eric H. Chou, Edward Chia-Cheng Lai, Huei-Kai Huang
JAMA Internal Medicine.2024; 184(1): 37. CrossRef Comparison of pharmacokinetic properties of alteplase and tenecteplase. The future of thrombolysis in acute ischemic stroke
Alessandro Marè, Simone Lorenzut, Francesco Janes, Carolina Gentile, Roberto Marinig, Yan Tereshko, Gian Luigi Gigli, Mariarosaria Valente, Giovanni Merlino
Expert Opinion on Drug Metabolism & Toxicology.2024; 20(1-2): 25. CrossRef Management of patients with proximal femur fractures under DOACs
Marc Maegele
European Journal of Trauma and Emergency Surgery.2024; 50(2): 359. CrossRef Acute coronary syndrome in patients treated by vitamin K antagonists or non-vitamin K antagonist oral anticoagulants: Proposed management algorithm for the first 48 hours
Alexandre Salaun, Emmanuel de Maistre, Marlène Daller, Chan Sombrun, Frédéric Chagué, Florence Bichat, Luc Rochette, Nicolas Danchin, Laurent Fauchier, Marianne Zeller, Yves Cottin
Archives of Cardiovascular Diseases.2024; 117(5): 351. CrossRef Assessing mortality and safety of IV thrombolysis in ischemic stroke patients on direct oral anticoagulants (DOACs): A systematic review and meta-analysis
Khadija Alam, Arsala Nadeem Khan, Afia Fatima, Abdul Haseeb, Duaa Jaffar, Abdullah Mussarat, Maryam Amir, Muhammad Owais Rana, Hamid Saeed, Abyaz Asmar
Clinical Neurology and Neurosurgery.2024; 246: 108523. CrossRef DOACs: role of anti-Xa and drug level monitoring
Siraj Mithoowani, Deborah Siegal
Hematology.2024; 2024(1): 178. CrossRef Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants
Thomas R. Meinel, Duncan Wilson, Henrik Gensicke, Jan F. Scheitz, Peter Ringleb, Ioana Goganau, Johannes Kaesmacher, Hee-Joon Bae, Do Yeon Kim, Pawel Kermer, Kentaro Suzuki, Kazumi Kimura, Kosmas Macha, Masatoshi Koga, Shinichi Wada, Valerian Altersberger
JAMA Neurology.2023; 80(3): 233. CrossRef Practical Nomogram Predicting Apixaban or Rivaroxaban Concentrations from Low-Molecular-Weight Heparin Anti-Xa Values: Special Interest in Acute Ischemic Stroke Patients
Charlyne Brakta, Alain Stépanian, Peggy Reiner, Maxime Delrue, Mikaël Mazighi, Emmanuel Curis, Virginie Siguret
Journal of Stroke.2023; 25(1): 126. CrossRef Poor Correlation of Rivaroxaban Concentration with the Routine Coagulation Screening Test in Chinese Patients with Atrial Fibrillation
Jiake He, Bo Zhu, Yang Shen, Jianping Hu, Kui Hong, Nizar Tlili
Journal of Clinical Pharmacy and Therapeutics.2023; 2023: 1. CrossRef Urine-based point-of-care testing for factor-Xa-inhibitors in acute ischemic stroke patients: a feasibility study
Thorsten R. Doeppner, Linus Olbricht, Toska Maxhuni, Omar Alhaj Omar, Ulrich J. Sachs, Martin B. Juenemann, Hagen B. Huttner, Stefan T. Gerner
Frontiers in Neurology.2023;[Epub] CrossRef Intravenous Thrombolysis for Acute Ischemic Stroke in Patients With Recent Direct Oral Anticoagulant Use: A Systematic Review and Meta‐Analysis
Malik Ghannam, Mohammad AlMajali, Milagros Galecio‐Castillo, Abdullah Al Qudah, Farid Khasiyev, Mahmoud Dibas, Dana Ghazaleh, Juan Vivanco‐Suarez, Cristian Morán‐Mariños, Mudassir Farooqui, Aaron Rodriguez‐Calienes, Prateeka Koul, Hannah Roeder, HyungSub
Journal of the American Heart Association.2023;[Epub] CrossRef Using a low–molecular weight heparin–calibrated anti–factor Xa assay to assess the concentration of apixaban and rivaroxaban
Henrik von Horn, Agnes Rasmusson, Lisbeth Söderblom, Rickard E Malmström, Jovan Antovic
International Journal of Laboratory Hematology.2022; 44(1): 163. CrossRef Differences Between Anticoagulated Patients With Ischemic Stroke Versus Intracerebral Hemorrhage
Fabian Schaub, Alexandros A. Polymeris, Sabine Schaedelin, Lisa Hert, Louisa Meya, Sebastian Thilemann, Christopher Traenka, Benjamin Wagner, David Seiffge, Henrik Gensicke, Gian Marco De Marchis, Leo Bonati, Stefan T. Engelter, Nils Peters, Philippe Lyre
Journal of the American Heart Association.2022;[Epub] CrossRef Thrombolyse intraveineuse dans l’ischémie cérébrale de phase aiguë : sur quoi reposent les recommandations ?
Alexandre Doucet, Vi Tuan Hua, Solène Moulin
Pratique Neurologique - FMC.2022; 13(1): 18. CrossRef Intravenous Thrombolytic Therapy for Treatment of Acute Ischemic Stroke in Patients Taking Non–Vitamin K Antagonist Oral Anticoagulants
David J. Seiffge
JAMA.2022; 327(8): 725. CrossRef Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants
Takashi Okada, Takeshi Yoshimoto, Shinichi Wada, Sohei Yoshimura, Tetsuya Chiba, Shuhei Egashira, Shunsuke Kimura, Masayuki Shiozawa, Manabu Inoue, Masafumi Ihara, Kazunori Toyoda, Hiroshi Takashima, Masatoshi Koga
Journal of the American Heart Association.2022;[Epub] CrossRef Thrombolysis in an Acute Ischemic Stroke Patient on Direct Anticoagulant Therapy Outside of the Traditional Time Window: A Case Report
Sofie Moorthamers, Nancy Mattar, Laeticia Frezals , Thierry Preseau, Marie-Dominique Gazagnes
Cureus.2022;[Epub] CrossRef The impact of direct oral anticoagulants on viscoelastic testing – A systematic review
Sebastian D. Sahli, Clara Castellucci, Tadzio R. Roche, Julian Rössler, Donat R. Spahn, Alexander Kaserer
Frontiers in Cardiovascular Medicine.2022;[Epub] CrossRef Safety of Recanalization Therapy in Acute Ischemic Stroke Patients on Direct Oral Anticoagulant Therapy
Yanxing Zhang, Huan Tang, Xiaohong Gui, Ye Du, Chenglong Wu
Annals of Indian Academy of Neurology.2022; 25(6): 1036. CrossRef A prospective observational study of the rapid detection of clinically‐relevant plasma direct oral anticoagulant levels following acute traumatic injury
D. Oberladstätter, W. Voelckel, C. Schlimp, J. Zipperle, B. Ziegler, O. Grottke, H. Schöchl
Anaesthesia.2021; 76(3): 373. CrossRef Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation
Thomas R. Meinel, Mattia Branca, Gian Marco De Marchis, Krassen Nedeltchev, Timo Kahles, Leo Bonati, Marcel Arnold, Mirjam R. Heldner, Simon Jung, Emmanuel Carrera, Elisabeth Dirren, Patrik Michel, Davide Strambo, Carlo W. Cereda, Giovanni Bianco, Georg K
Annals of Neurology.2021; 89(1): 42. CrossRef Direct Oral Anticoagulants Plasma Levels Measurement: Clinical Usefulness from Trials and Real-World Data
Francesca Renon, Anna Rago, Biagio Liccardo, Antonello D'Andrea, Lucia Riegler, Paolo Golino, Gerardo Nigro, Vincenzo Russo
Seminars in Thrombosis and Hemostasis.2021; 47(02): 150. CrossRef Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants
David J Seiffge, Thomas Meinel, Jan Christoph Purrucker, Johannes Kaesmacher, Urs Fischer, Duncan Wilson, Teddy Y Wu
Journal of Neurology, Neurosurgery & Psychiatry.2021; 92(5): 534. CrossRef European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
Eivind Berge, William Whiteley, Heinrich Audebert, GM De Marchis, Ana Catarina Fonseca, Chiara Padiglioni, Natalia Pérez de la Ossa, Daniel Strbian, Georgios Tsivgoulis, Guillaume Turc
European Stroke Journal.2021; 6(1): I. CrossRef Off-label use of intravenous thrombolysis for acute ischemic stroke: a critical appraisal of randomized and real-world evidence
Georgios Tsivgoulis, Odysseas Kargiotis, Gianmarco De Marchis, Martin Kohrmann, Else Charlotte Sandset, Theodore Karapanayiotides, Diana Aguiar de Sousa, Amrou Sarraj, Apostolos Safouris, Klearchos Psychogios, Konstantinos Vadikolias, Didier Leys, Peter D
Therapeutic Advances in Neurological Disorders.2021;[Epub] CrossRef Administering Thrombolysis for Acute Ischemic Stroke in Patients Taking Direct Oral Anticoagulants
David J. Seiffge, Duncan Wilson, Teddy Yuan-Hao Wu
JAMA Neurology.2021; 78(5): 515. CrossRef Updated recommendations for the treatment of venous thromboembolism
Junshik Hong, Seo-Yeon Ahn, Yoo Jin Lee, Ji Hyun Lee, Jung Woo Han, Kyoung Ha Kim, Ho-Young Yhim, Seung-Hyun Nam, Hee-Jin Kim, Jaewoo Song, Sung-Hyun Kim, Soo-Mee Bang, Jin Seok Kim, Yeung-Chul Mun, Sung Hwa Bae, Hyun Kyung Kim, Seongsoo Jang, Rojin Park,
BLOOD RESEARCH.2021; 56(1): 6. CrossRef Challenges of Acute Ischemic Stroke Treatment in Orally Anticoagulated Patients via Telemedicine
Jordi Kühne Escolà, Simon Nagel, Verena Panitz, Tilman Reiff, Alexander Gutschalk, Christoph Gumbinger, Jan Christoph Purrucker
Journal of Clinical Medicine.2021; 10(9): 1956. CrossRef Update on laboratory testing and hemostasis assessment in patients receiving direct oral anticoagulants (DOACs)
Vasilios Perifanis, Nikolaos Neokleous, Dimitrios A. Tsakiris
Thrombosis Update.2021; 5: 100084. CrossRef Acute Stroke Treatment in an Anticoagulated Patient: When Is Thrombolysis an Option?
Teresa Siller, Arvind Chandratheva, Philipp Bücke, David J. Werring, David Seiffge
Current Treatment Options in Neurology.2021;[Epub] CrossRef Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants
Shima Shahjouei, Georgios Tsivgoulis, Nitin Goyal, Alireza Sadighi, Ashkan Mowla, Ming Wang, David J. Seiffge, Ramin Zand
Stroke.2020; 51(2): 533. CrossRef Assessing and Reversing the Effect of Direct Oral Anticoagulants on Coagulation
Arielle Langer, Jean M. Connors
Anesthesiology.2020; 133(1): 223. CrossRef Diagnostic performance of coagulation indices for direct oral anticoagulant concentration
Hanxu Zhang, Zhiyan Liu, Guangyan Mu, Zhe Wang, Shuang Zhou, Qiufen Xie, Lingyue Ma, Zining Wang, Kun Hu, Yanjun Gong, Jie Jiang, Qian Xiang, Yimin Cui
Thrombosis Research.2020; 195: 171. CrossRef Overview and Practical Application of Coagulation Assays in Managing Anticoagulation with Direct Oral Anticoagulants (DOACs)
Jessica Rimsans, Jonathan Douxfils, Maureen A Smythe, Robert C Gosselin
Current Pharmacology Reports.2020; 6(5): 241. CrossRef Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system
Nicholas Jakowenko, Steffany Nguyen, Melanie Ruegger, Ashley Dinh, Eric Salazar, Kevin R. Donahue
Thrombosis Research.2020; 196: 276. CrossRef 2018 Korean Heart Rhythm Society Guidelines for Non-Vitamin K Antagonist Oral Anticoagulants
Yae Min Park, Hyung Wook Park, Jung Myung Lee, Jin-Kyu Park, Ki Hong Lee, Jin-Bae Kim, Young Soo Lee, Boyoung Joung
The Korean Journal of Medicine.2019; 94(1): 57. CrossRef Cerebral Ischemia in Patients on Direct Oral Anticoagulants
Kosmas Macha, Armin Marsch, Gabriela Siedler, Lorenz Breuer, Erwin F. Strasser, Tobias Engelhorn, Stefan Schwab, Bernd Kallmünzer
Stroke.2019; 50(4): 873. CrossRef Clinical presentation, diagnostic findings and management of cerebral ischemic events in patients on treatment with non-vitamin K antagonist oral anticoagulants – A systematic review
Thomas Raphael Meinel, Sebastién Frey, Marcel Arnold, Sarah Kendroud, Urs Fischer, Johannes Kaesmacher, Mirjam Rachel Heldner, Simon Jung, Marcel M. Daadi
PLOS ONE.2019; 14(3): e0213379. CrossRef Patients on NOACs in the Emergency Room
Stefan T. Gerner, Hagen B. Huttner
Current Neurology and Neuroscience Reports.2019;[Epub] CrossRef Atrial fibrillation and stroke: a practical guide
Jonathan Gordon Best, Robert Bell, Mohammed Haque, Arvind Chandratheva, David John Werring
Practical Neurology.2019; 19(3): 208. CrossRef Lumbar puncture after direct oral anticoagulant (DOAC) reversal: a proposed algorithm for the emergency department
Eugenia Rota, Sergio Agosti, Roberta Risso, Nicola Morelli
Internal and Emergency Medicine.2019; 14(7): 1175. CrossRef Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians
J. Douxfils, W. Ageno, C.‐M. Samama, S. Lessire, H. ten Cate, P. Verhamme, J. ‐M. Dogné, F. Mullier
Journal of Thrombosis and Haemostasis.2018; 16(2): 209. CrossRef Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage
David J. Seiffge, Georg Kägi, Patrik Michel, Urs Fischer, Yannick Béjot, Susanne Wegener, Marialuisa Zedde, Guillaume Turc, Charlotte Cordonnier, Peter S. Sandor, Gilles Rodier, Andrea Zini, Manuel Cappellari, Sabine Schädelin, Alexandros A. Polymeris, Da
Annals of Neurology.2018; 83(3): 451. CrossRef
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel, Peter Verhamme, Tatjana S Potpara, Pierre Albaladejo, Matthias Antz, Lien Desteghe, Karl Georg Haeusler, Jonas Oldgren, Holger Reinecke, Vanessa Roldan-Schilling, Nigel Rowell, Peter Sinnaeve, Ronan Collins, A John Camm, Hein Heidbüchel, Greg
European Heart Journal.2018; 39(16): 1330. CrossRef The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary
Jan Steffel, Peter Verhamme, Tatjana S Potpara, Pierre Albaladejo, Matthias Antz, Lien Desteghe, Karl Georg Haeusler, Jonas Oldgren, Holger Reinecke, Vanessa Roldan-Schilling, Nigel Rowell, Peter Sinnaeve, Ronan Collins, A John Camm, Hein Heidbüchel, Greg
EP Europace.2018; 20(8): 1231. CrossRef Thrombolysis on direct oral anticoagulants: the ‘grey area’
E. Rota, S. Agosti, R. Risso, N. Morelli
European Journal of Neurology.2018;[Epub] CrossRef Reduction of the turn‐around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method
A.‐S. Dincq, S. Lessire, G. Pirard, R. Siriez, M. Guldenpfennig, J. Baudar, J. Favresse, J. Douxfils, F. Mullier
International Journal of Laboratory Hematology.2018;[Epub] CrossRef Safety of Recanalization Therapy in Patients with Acute Ischemic Stroke Under Anticoagulation: A Systematic Review and Meta-Analysis
Mingsu Liu, Yang Zheng, Guangqin Li
Journal of Stroke and Cerebrovascular Diseases.2018; 27(9): 2296. CrossRef Management of patients with stroke treated with direct oral anticoagulants
D. J. Seiffge, A. A. Polymeris, J. Fladt, P. A. Lyrer, S. T. Engelter, Gian Marco De Marchis
Journal of Neurology.2018; 265(12): 3022. CrossRef Testing and monitoring direct oral anticoagulants
Jean M. Connors
Blood.2018; 132(19): 2009. CrossRef
|